HOME
KOREAN
About Us
Company Overview
BOD and SAB
History
Contact us
R&D
Core Technology
Products
Services
Investor Relations
Stock Price Information
Investor Updates
Media
Notices
Press Release
PR Video
Careers
We're Recruiting
Careers Guide
Antibody Therapeutics for Life
Notices
Press Release
PR Video
Notices
No
Title
Written by
Written date
Inquire
39
PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme.
Admin
2019-01-14
4,008
38
`` Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model`` is now indexed on PubMed.
Admin
2019-01-14
2,546
37
``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2`` is now indexed on PubMed.
Admin
2019-01-14
2,520
36
Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.
Admin
2019-01-14
5,650
35
Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
Admin
2019-01-14
2,342
34
Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at BOSTON CEO on May 10th, 2018.
Admin
2019-01-14
2,785
33
PharmAbcine was introduced today in The South China Morning Post-2018 South Korea Business Report.
Admin
2019-01-14
1,705
32
PharmAbcine enters collaboration with MSD focused on clinical evaluation of TTAC-0001 in combination with KEYTRUDA¢ç (pembrolizumab) in recurrent glioblastoma and breast cancer.
Admin
2019-01-14
1,855
31
Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
Admin
2019-01-14
3,068
30
Dr. Jin-San Yoo, CEO of PharmAbcine is invited to 36th JP Morgan Healthcare Conference.
Admin
2019-01-14
2,474
1
2
3
4
5
6
7
8
9
--Search--
Title
Written by
content